Litcius/Paper detail

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

Kirsten E. Lyke, Andrea A. Berry, Kaitlin Mason, Azza H. Idris, Mark O’Callahan, Myra Happe, Larisa Strom, Nina M. Berkowitz, Mercy Guech, Zonghui Hu, Mike Castro, Manjula Basappa, Lu Wang, Kwang Low, LaSonji A. Holman, Floreliz Mendoza, Ingelise J. Gordon, Sarah H. Plummer, Olga Trofymenko, Kathleen Strauss, Sudhaunshu Joshi, Biraj Shrestha, Matthew Adams, Andrezza Campos Chagas, Jittawadee Murphy, Judy Stein, Somia P. Hickman, Andrew J. McDougal, Bob C. Lin, Sandeep Narpala, Sandra Vazquez, Leonid Serebryannyy, Adrian B. McDermott, Martin R. Gaudinski, Edmund V. Capparelli, Emily E. Coates, Richard L Wu, Julie E. Ledgerwood, Lesia Dropulic, Robert A. Seder, Cheryl Young, Colleen Boyce, Jennifer L. Winkler, Susan Holian, Nancy Greenberg, Shirley St. George, Alyson Kwon, Brenda Dorsey, Ana Raquel Da Costa, William Edward Witt, Daryl Grays, Arren Gapasin, Paula J. Bernal, Jeffrey Floyd, Eric Goldstein, Leslie Howe, Myoung-Hee Lee, Jennifer A. Marron, Kelly A Brooks, Lisa Turek, Patricia Farley, Shantel Frels, Delores Booth, Jason G. Gall, Kevin Carlton, Gabriela Albright, Nadia Amharref, Kandace Atallah, Sashikanth Banappagari, Niutish Bastani, Daniel Blackstock, Bobby Boonyaratanakornkit, Elizabeth J. Carey, Adam Charlton, Rajoshi Chaudhuri, Alegria M. Caringal, Mingzhong Chen, Peifeng Chen, Wei Cheng, Daniel B. Gowetski, Krishana Gulla, Erica Hastings, Joe Horwitz, Vera B. Ivleva, Dan Kordella, Lisa A. Kueltzo, Sara K. Lagler, Matt Le, James Lee, Paula Lei, Yile Li, Attila Nagy, Aakash Patel, Peyi Runsewe, Will Shadrick, Shamitha Shetty, Hairong Wang, Calvin Webber, Farah Vejzagic, Yoojung Yang

2023The Lancet Infectious Diseases40 citationsDOIOpen Access PDF

Topics & Concepts

MalariaMonoclonal antibodyMedicinePlasmodium falciparumMalaria vaccineVirologyVaccinationAntibodyInternal medicineImmunologyMalaria Research and ControlParasitic Diseases Research and TreatmentParasites and Host Interactions
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial | Litcius